DIVI'S LABORATORIES LIMITED

Business Segments Divi's Laboratories Limited

Equities

DIVISLAB

INE361B01024

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:35:02 13/04/2026 pm IST			5-day change	1st Jan Change
6,070.00 ^INR	-0.76%		+4.28%	-5.04%

01/04	Avendus Spark Upgrades Divi's Laboratories to Reduce from Sell, Price Target is INR5,840	MT
12/02	Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Life Sciences Tools and Services
Active Pharmaceutical Ingredients, Intermediates and Nutraceutical Ingredients						6.97TCr	8.96TCr	7.77TCr	7.84TCr	9.36TCr
Total Assets						11TCr	13TCr	14TCr	15TCr	17TCr
Interest Expense						-39L	-37L	-33L	-3Cr	-2Cr
Income Tax Expense						681.75Cr	723.05Cr	545.25Cr	563Cr	725Cr
CAPEX						-910.19Cr	-713.2Cr	-473.02Cr	-1TCr	-1.44TCr
EBT						2.67TCr	3.68TCr	2.37TCr	2.16TCr	2.92TCr
D&A						252.62Cr	308.33Cr	339.26Cr	375Cr	399Cr
Net Income						1.98TCr	2.96TCr	1.82TCr	1.6TCr	2.19TCr

Geographical Revenue Distribution History

Geographical breakdown of sales (INR)

Fiscal Period: March	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Other Countries						4.68TCr	5.92TCr	4.95TCr	4.79TCr	5.04TCr
Total Assets						33L	1.4Cr	1.13Cr	-	-
CAPEX						-	-	-	-	-
Switzerland						-	-	-	1.02TCr	1.91TCr
USA						1.38TCr	2TCr	1.85TCr	1.05TCr	1.31TCr
Total Assets						39L	2.79Cr	2.71Cr	2Cr	2Cr
India						912.36Cr	1.04TCr	975.58Cr	984Cr	1.11TCr
Total Assets						4.54TCr	4.88TCr	4.98TCr	5.64TCr	6.71TCr
CAPEX						-	-	-	-	-

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!